{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:30:48Z","timestamp":1783945848349,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MSIT(Ministry of Science and ICT), Korea, under the ICAN(ICT Challenge and Advanced Network of HRD) program","award":["IITP-2022-RS-2022-00156439"],"award-info":[{"award-number":["IITP-2022-RS-2022-00156439"]}]},{"name":"Medical data-driven hospital support project through the Korea Health Information Service(KHIS), funded by the Ministry of Health & Welfare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Metabolic abnormalities such as dyslipidemia, glucose and high blood pressure are common in diabetic patients. Visit-to-visit variabilities in these measures have been reported as potential residual cardiovascular risk factors. However, the relationship between these variabilities and their effects on cardiovascular prognosis have not been studied.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 22,310 diabetic patients with \u2265\u20093 measurements of systolic blood pressure (SBP), blood glucose, total cholesterol (TC), and triglyceride (TG) levels during a minimum of three years at three tertiary general hospitals were selected. They were divided into high\/low variability groups for each variable based on the coefficient of variation (CV) values. The primary outcome was the incidence of major adverse cardiovascular events (MACE), a composite of cardiovascular death, myocardial infarction, and stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All high CV groups had a higher incidence of MACE than those with low CV (6.0% vs. 2.5% for SBP-CV groups, 5.5% vs. 3.0% for TC-CV groups, 4.7% vs. 3.8% for TG-CV groups, 5.8% vs. 2.7% for glucose-CV groups). In multivariable Cox regression analysis,, high SBP-CV (HR 1.79 [95% CI 1.54\u20132.07], p\u2009&lt;\u20090.01), high TC-CV (HR 1.54 [95% CI 1.34\u20131.77], p\u2009&lt;\u20090.01), high TG-CV (HR 1.15 [95% CI 1.01\u20131.31], p\u2009=\u20090.040) and high glucose-CV (HR 1.61 [95% CI 1.40\u20131.86], p\u2009&lt;\u20090.01) were independent predictors of MACE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Variability of SBP, TC, TG and glucose are important residual risk factors for cardiovascular events in diabetic patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-01848-x","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:42:43Z","timestamp":1684161763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of metabolic parameters\u2019 variability on cardiovascular outcomes in diabetic patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Subin","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hwa","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Joon","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"issue":"1","key":"1848_CR1","doi-asserted-by":"publisher","first-page":"e000427","DOI":"10.1136\/bmjdrc-2017-000427","volume":"5","author":"HF Jelinek","year":"2017","unstructured":"Jelinek HF, Osman WM, Khandoker AH, Khalaf K, Lee S, Almahmeed W, Alsafar HS. Clinical profiles, comorbidities and complications of type 2 diabetes mellitus in patients from United Arab Emirates. BMJ Open Diabetes Res Care. 2017;5(1):e000427.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1848_CR2","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.2147\/DMSO.S255695","volume":"13","author":"D Abdissa","year":"2020","unstructured":"Abdissa D, Kene K. Prevalence and determinants of Hypertension among Diabetic Patients in Jimma University Medical Center, Southwest Ethiopia, 2019. Diabetes Metab Syndr Obes. 2020;13:2317\u201325.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"1848_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2014.18574","volume":"313","author":"CA Emdin","year":"2015","unstructured":"Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603\u201315.","journal-title":"JAMA"},{"issue":"7","key":"1848_CR4","doi-asserted-by":"publisher","first-page":"e016947","DOI":"10.1161\/JAHA.120.016947","volume":"10","author":"AD Kaze","year":"2021","unstructured":"Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic Dyslipidemia and Cardiovascular Outcomes in type 2 diabetes Mellitus: findings from the look AHEAD study. J Am Heart Assoc. 2021;10(7):e016947.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"1848_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1161\/HYPERTENSIONAHA.114.03903","volume":"64","author":"KM Diaz","year":"2014","unstructured":"Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, Muntner P. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64(5):965\u201382.","journal-title":"Hypertension"},{"issue":"15","key":"1848_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jacc.2015.02.017","volume":"65","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Breazna A, DeMicco DA, Wun CC, Messerli FH, Committee TNTS, Investigators. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial. J Am Coll Cardiol. 2015;65(15):1539\u201348.","journal-title":"J Am Coll Cardiol"},{"key":"1848_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2015.10.110","volume":"244","author":"E Boey","year":"2016","unstructured":"Boey E, Gay GM, Poh KK, Yeo TC, Tan HC, Lee CH. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: a 5-year follow-up study. Atherosclerosis. 2016;244:86\u201392.","journal-title":"Atherosclerosis"},{"key":"1848_CR8","doi-asserted-by":"publisher","first-page":"39633","DOI":"10.1038\/srep39633","volume":"6","author":"D Xu","year":"2016","unstructured":"Xu D, Fang H, Xu W, Yan Y, Liu Y, Yao B. Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China. Sci Rep. 2016;6:39633.","journal-title":"Sci Rep"},{"issue":"1","key":"1848_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12933-022-01681-8","volume":"21","author":"SM Koh","year":"2022","unstructured":"Koh SM, Chung SH, Yum YJ, Park SJ, Joo HJ, Kim YH, Kim EJ. Comparison of the effects of triglyceride variability and exposure estimate on clinical prognosis in diabetic patients. Cardiovasc Diabetol. 2022;21(1):245.","journal-title":"Cardiovasc Diabetol"},{"issue":"25","key":"1848_CR10","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"group Sw, collaboration ESCCr","year":"2021","unstructured":"group Sw, collaboration ESCCr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"issue":"23","key":"1848_CR11","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.118.034978","volume":"138","author":"MK Kim","year":"2018","unstructured":"Kim MK, Han K, Park YM, Kwon HS, Kang G, Yoon KH, Lee SH. Associations of variability in blood pressure, glucose and cholesterol concentrations, and body Mass Index with Mortality and Cardiovascular Outcomes in the General Population. Circulation. 2018;138(23):2627\u201337.","journal-title":"Circulation"},{"issue":"4","key":"1848_CR12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/dom.13193","volume":"20","author":"SS Wightman","year":"2018","unstructured":"Wightman SS, Sainsbury CAR, Jones GC. Visit-to-visit HbA1c variability and systolic blood pressure (SBP) variability are significantly and additively associated with mortality in individuals with type 1 diabetes: an observational study. Diabetes Obes Metab. 2018;20(4):1014\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"1848_CR13","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/dom.12976","volume":"19","author":"A Ceriello","year":"2017","unstructured":"Ceriello A, De Cosmo S, Rossi MC, Lucisano G, Genovese S, Pontremoli R, Fioretto P, Giorda C, Pacilli A, Viazzi F, et al. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes. Diabetes Obes Metab. 2017;19(11):1570\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"1848_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/2047487317707293","volume":"24","author":"N Hashemi Madani","year":"2017","unstructured":"Hashemi Madani N, Ismail-Beigi F, Khamseh ME, Malek M, Ebrahimi Valojerdi A. Predictive and explanatory factors of cardiovascular disease in people with adequately controlled type 2 diabetes. Eur J Prev Cardiol. 2017;24(11):1181\u20139.","journal-title":"Eur J Prev Cardiol"},{"issue":"9718","key":"1848_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","volume":"375","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Howard SC, Dolan E, O\u2019Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895\u2013905.","journal-title":"Lancet"},{"issue":"37","key":"1848_CR16","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1093\/eurheartj\/ehx250","volume":"38","author":"E Vidal-Petiot","year":"2017","unstructured":"Vidal-Petiot E, Stebbins A, Chiswell K, Ardissino D, Aylward PE, Cannon CP, Ramos Corrales MA, Held C, Lopez-Sendon JL, Stewart RAH, et al. Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial. Eur Heart J. 2017;38(37):2813\u201322.","journal-title":"Eur Heart J"},{"issue":"3","key":"1848_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.amjcard.2016.10.037","volume":"119","author":"S Bangalore","year":"2017","unstructured":"Bangalore S, Fayyad R, Messerli FH, Laskey R, DeMicco DA, Kastelein JJ, Waters DD. Relation of variability of low-density lipoprotein cholesterol and blood pressure to events in patients with previous myocardial infarction from the IDEAL trial. Am J Cardiol. 2017;119(3):379\u201387.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1848_CR18","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1111\/dom.13828","volume":"21","author":"M Chiriaco","year":"2019","unstructured":"Chiriaco M, Pateras K, Virdis A, Charakida M, Kyriakopoulou D, Nannipieri M, Emdin M, Tsioufis K, Taddei S, Masi S, et al. Association between blood pressure variability, cardiovascular disease and mortality in type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2019;21(12):2587\u201398.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"1848_CR19","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1161\/CIRCULATIONAHA.113.002717","volume":"128","author":"J Hata","year":"2013","unstructured":"Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, Patel A, Neal B, Glasziou P, Hamet P, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation. 2013;128(12):1325\u201334.","journal-title":"Circulation"},{"issue":"1","key":"1848_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12933-020-01030-7","volume":"19","author":"CRL Cardoso","year":"2020","unstructured":"Cardoso CRL, Leite NC, Salles GF. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study. Cardiovasc Diabetol. 2020;19(1):50.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1848_CR21","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/0002-8703(94)90393-X","volume":"127","author":"BE Kreger","year":"1994","unstructured":"Kreger BE, Odell PM, D\u2019Agostino RB, Wilson PF. Long-term intraindividual cholesterol variability: natural course and adverse impact on morbidity and mortality\u2013the Framingham Study. Am Heart J. 1994;127(6):1607\u201314.","journal-title":"Am Heart J"},{"issue":"48","key":"1848_CR22","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","volume":"38","author":"MK Kim","year":"2017","unstructured":"Kim MK, Han K, Kim HS, Park YM, Kwon HS, Yoon KH, Lee SH. Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study. Eur Heart J. 2017;38(48):3560\u20136.","journal-title":"Eur Heart J"},{"issue":"5","key":"1848_CR23","doi-asserted-by":"publisher","first-page":"e027639","DOI":"10.1161\/JAHA.122.027639","volume":"12","author":"SM Manemann","year":"2023","unstructured":"Manemann SM, Bielinski SJ, Moser ED, St Sauver JL, Takahashi PY, Roger VL, Olson JE, Chamberlain AM, Remaley AT, Decker PA, et al. Variability in lipid levels and risk for Cardiovascular Disease: an Electronic Health Record-Based Population Cohort Study. J Am Heart Assoc. 2023;12(5):e027639.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"1848_CR24","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"JC LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, Gotto AM, Greten H, Kastelein JJ, Shepherd J, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352(14):1425\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"1848_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12933-021-01421-4","volume":"20","author":"MC Wang","year":"2021","unstructured":"Wang MC, Li CI, Liu CS, Lin CH, Yang SY, Li TC, Lin CC. Effect of blood lipid variability on mortality in patients with type 2 diabetes: a large single-center cohort study. Cardiovasc Diabetol. 2021;20(1):228.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"1848_CR26","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1111\/dom.14093","volume":"22","author":"EYF Wan","year":"2020","unstructured":"Wan EYF, Yu EYT, Chin WY, Barrett JK, Mok AHY, Lau CST, Wang Y, Wong ICK, Chan EWY, Lam CLK. Greater variability in lipid measurements associated with cardiovascular disease and mortality: a 10-year diabetes cohort study. Diabetes Obes Metab. 2020;22(10):1777\u201388.","journal-title":"Diabetes Obes Metab"},{"key":"1848_CR27","doi-asserted-by":"crossref","unstructured":"Wang A, Liu X, Xu J, Han X, Su Z, Chen S, Zhang N, Wu S, Wang Y, Wang Y. Visit-to-Visit Variability of Fasting Plasma Glucose and the Risk of Cardiovascular Disease and All-Cause Mortality in the General Population. J Am Heart Assoc 2017, 6(12).","DOI":"10.1161\/JAHA.117.006757"},{"issue":"29","key":"1848_CR28","doi-asserted-by":"publisher","first-page":"e16317","DOI":"10.1097\/MD.0000000000016317","volume":"98","author":"JH Yu","year":"2019","unstructured":"Yu JH, Han K, Park S, Lee DY, Nam GE, Seo JA, Kim SG, Baik SH, Park YG, Kim SM, et al. Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes: a nationwide population-based study. Med (Baltim). 2019;98(29):e16317.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1848_CR29","first-page":"19","volume":"8","author":"MJ Stewart","year":"1994","unstructured":"Stewart MJ, Jyothinagaram S, McGinley IM, Padfield PL. Cardiovascular effects of cigarette smoking: ambulatory blood pressure and BP variability. J Hum Hypertens. 1994;8(1):19\u201322.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"1848_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1472-8206.1999.tb00010.x","volume":"13","author":"I Ragueneau","year":"1999","unstructured":"Ragueneau I, Michaud P, Demolis JL, Moryusef A, Jaillon P, Funck-Brentano C. Effects of cigarette smoking on short-term variability of blood pressure in smoking and non smoking healthy volunteers. Fundam Clin Pharmacol. 1999;13(4):501\u20137.","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01848-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01848-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:44:21Z","timestamp":1684161861000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01848-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1848"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01848-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Review Board of each of the participating institute. Written informed consent was waived due to the retrospective study design and use of anonymized data with minimal risk to the study subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read an approved the manuscript of final version. Competing interests The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}